type 1 diabetes and glp-1 Evolution of GLP‐1 Receptor Agonists for Treatment Type 1 on a GLP-1

Turn left onto S Ott St , then right onto W Allen St

Among bone turnover markers, Tartrate-resistant acid phosphatase 5b (TRACP 5b) and C-terminal telopeptide of type I collagen (-CTX) reflect osteoclast activity, whereas P1NP reflects bone formation

Common side effects across the class are gastrointestinal (nausea, vomiting, diarrhea, constipation), most pronounced during dose escalation

Ashrafizadeh M, Rafiei H, Mohammadinejad R, Farkhondeh T, Samarghandian S

Glucagon-like peptide-1 (GLP-1) drugs help people lose weight by making them feel fuller with less food and by signaling the brain that the stomach contains food, reducing their appetite and cravings